0001127602-22-016898.txt : 20220606
0001127602-22-016898.hdr.sgml : 20220606
20220606170359
ACCESSION NUMBER: 0001127602-22-016898
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220511
FILED AS OF DATE: 20220606
DATE AS OF CHANGE: 20220606
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chaguturu Sreekanth K
CENTRAL INDEX KEY: 0001928726
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-01011
FILM NUMBER: 22998791
MAIL ADDRESS:
STREET 1: ONE CVS DRIVE
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CVS HEALTH Corp
CENTRAL INDEX KEY: 0000064803
STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
IRS NUMBER: 050494040
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
BUSINESS PHONE: 4017651500
MAIL ADDRESS:
STREET 1: ONE CVS DR.
CITY: WOONSOCKET
STATE: RI
ZIP: 02895
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CAREMARK CORP
DATE OF NAME CHANGE: 20070509
FORMER COMPANY:
FORMER CONFORMED NAME: CVS/CAREMARK CORP
DATE OF NAME CHANGE: 20070322
FORMER COMPANY:
FORMER CONFORMED NAME: CVS CORP
DATE OF NAME CHANGE: 19970128
3/A
1
form3a.xml
PRIMARY DOCUMENT
X0206
3/A
2022-05-11
2022-05-19
0
0000064803
CVS HEALTH Corp
CVS
0001928726
Chaguturu Sreekanth K
ONE CVS DRIVE
WOONSOCKET
RI
02895
1
EVP and Chief Medical Officer
Common Stock (RSU)
996
D
Common Stock (RSU)
354
D
Common Stock (RSU)
2154
D
Common Stock (RSU)
1258
D
Common Stock (RSU)
2085
D
Common Stock (RSU)
2776
D
Common Stock (RSU)
6182
D
Common Stock
2342.7803
D
Stock Option
75.27
2020-11-29
2029-11-29
Common Stock
5952
D
Stock Option
58.34
2021-04-01
2030-04-01
Common Stock
9579
D
Stock Option
74.30
2022-04-01
2031-04-01
Common Stock
9502
D
Stock Option
101.09
2023-04-01
2032-04-01
Common Stock
12993
D
Consists of Restricted Stock Units (RSUs) awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions lapse on the third anniversary of the grant date.
Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse on 2/28/2023.
Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.
Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.
Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in two equal installments beginning 2/26/2023.
Consists of RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions on remaining RSUs lapse in three equal installments beginning 4/1/2023.
Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal installments beginning 4/1/2023.
Option becomes exercisable in four equal annual installments, commencing 11/29/2020.
Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
Option becomes exercisable in four equal annual installments, commencing 4/1/2023.
/s/ Sreekanth K. Chaguturu
2022-06-06